Loading...

DENALI CAPITAL ACQUISITION CORP Capital Structure Changes 8-K Filing

DNL

DENALI CAPITAL ACQUISITION CORP

()

2025 8-K

Leadership Changes

Securities Update

Merger Announcement

Merger Agreement Approved

Investment Agreement

Merger of Equals

Asset Acquisitions

Shareholder Meeting

Delisting Notice

Business Combination Extension

Business Extension

Business Combination Extension

Deadline Extension

Deadline Extension

Deadline Extension

Nasdaq Compliance Notice

Deadline Extension

Merger Agreement

Convertible Promissory Note...

Dismissal and Appointment o...

Convertible Promissory Note...

Business Combination Announ...

Termination of Merger Agree...

Shareholder Meeting

Postponement of Shareholder...

Amended and Restated Subscr...

Convertible Promissory Note...

Investor Presentation

Merger Agreement and Conver...

Merger Agreement

External Links:

Semnur Pharmaceuticals, Inc. filed a report on December 3, 2025, updating its securities description and amending its Certificate of Incorporation and Bylaws since the end of its fiscal year on December 31, 2024.

AI Assistant

DENALI CAPITAL ACQUISITION CORP

2025

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.